| Gene Symbol | Gene ID | Gene Info | 
|---|---|---|
| 
                            RXRA
                            
                            
                         | ENSG00000186350.8 | retinoid X receptor alpha | 
| 
                            NR2F6
                            
                            
                         | ENSG00000160113.5 | nuclear receptor subfamily 2 group F member 6 | 
| 
                            NR2C2
                            
                            
                         | ENSG00000177463.11 | nuclear receptor subfamily 2 group C member 2 | 
| CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot | 
|---|---|---|---|---|---|---|
| chr3_15030312_15030669 | NR2C2 | 14932 | 0.200509 | -0.92 | 3.6e-04 | Click! | 
| chr3_15030696_15031049 | NR2C2 | 14550 | 0.201382 | -0.92 | 3.9e-04 | Click! | 
| chr3_15086795_15086946 | NR2C2 | 10710 | 0.183929 | -0.78 | 1.2e-02 | Click! | 
| chr3_15086083_15086349 | NR2C2 | 10056 | 0.186040 | -0.78 | 1.3e-02 | Click! | 
| chr3_15085490_15085641 | NR2C2 | 9405 | 0.188270 | -0.76 | 1.7e-02 | Click! | 
| chr19_17355580_17355772 | NR2F6 | 363 | 0.697927 | -0.73 | 2.7e-02 | Click! | 
| chr19_17355970_17356244 | NR2F6 | 642 | 0.464791 | -0.71 | 3.1e-02 | Click! | 
| chr19_17354372_17354523 | NR2F6 | 866 | 0.344246 | 0.41 | 2.8e-01 | Click! | 
| chr19_17347232_17347383 | NR2F6 | 8006 | 0.075779 | 0.36 | 3.5e-01 | Click! | 
| chr19_17347456_17347847 | NR2F6 | 7662 | 0.076315 | 0.31 | 4.2e-01 | Click! | 
| chr9_137297302_137297453 | RXRA | 1051 | 0.605979 | -0.90 | 9.7e-04 | Click! | 
| chr9_137285059_137285256 | RXRA | 13271 | 0.220647 | -0.88 | 1.7e-03 | Click! | 
| chr9_137285606_137285757 | RXRA | 12747 | 0.222225 | -0.88 | 1.8e-03 | Click! | 
| chr9_137287605_137287956 | RXRA | 10648 | 0.228862 | -0.87 | 2.5e-03 | Click! | 
| chr9_137290468_137290672 | RXRA | 7858 | 0.239935 | -0.86 | 3.2e-03 | Click! | 
Move your cursor over a bar to see sample name and corresponding Z-value.
| Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability | 
|---|---|---|---|---|---|
| chr9_34253979_34254272 | 2.58 | ENSG00000222426 | . | 28543 | 0.11 | 
| chr15_80466917_80467209 | 2.37 | FAH | fumarylacetoacetate hydrolase (fumarylacetoacetase) | 18770 | 0.21 | 
| chr5_133774585_133774736 | 1.95 | CDKN2AIPNL | CDKN2A interacting protein N-terminal like | 27071 | 0.14 | 
| chr15_52386582_52387272 | 1.89 | CTD-2184D3.5 |  | 5793 | 0.16 | 
| chr15_74232933_74233272 | 1.82 | LOXL1-AS1 | LOXL1 antisense RNA 1 | 12513 | 0.14 | 
| chr22_43076471_43076622 | 1.77 | A4GALT | alpha 1,4-galactosyltransferase | 14446 | 0.14 | 
| chr22_50356250_50357150 | 1.75 | PIM3 | pim-3 oncogene | 2539 | 0.27 | 
| chr11_65257627_65258285 | 1.71 | SCYL1 | SCY1-like 1 (S. cerevisiae) | 34592 | 0.08 | 
| chr1_156675699_156676565 | 1.68 | CRABP2 | cellular retinoic acid binding protein 2 | 524 | 0.6 | 
| chr11_10396586_10396737 | 1.67 | ENSG00000221574 | . | 24203 | 0.17 | 
| chr7_77827088_77827239 | 1.60 | RP5-1185I7.1 |  | 207426 | 0.03 | 
| chr18_68090011_68090162 | 1.57 | ENSG00000264059 | . | 60627 | 0.13 | 
| chr11_131758279_131758430 | 1.54 | AP004372.1 |  | 8648 | 0.25 | 
| chr1_94128945_94129096 | 1.54 | BCAR3 | breast cancer anti-estrogen resistance 3 | 17906 | 0.22 | 
| chr18_46133340_46133491 | 1.54 | ENSG00000266276 | . | 63556 | 0.11 | 
| chr22_31479008_31479415 | 1.53 | RP3-412A9.16 |  | 340 | 0.68 | 
| chr14_94432375_94432526 | 1.52 | ASB2 | ankyrin repeat and SOCS box containing 2 | 7979 | 0.16 | 
| chr2_43152776_43153425 | 1.45 | HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 133368 | 0.05 | 
| chr11_45880665_45880817 | 1.45 | CRY2 | cryptochrome 2 (photolyase-like) | 11784 | 0.14 | 
| chr3_79217524_79217675 | 1.44 | ROBO1 | roundabout, axon guidance receptor, homolog 1 (Drosophila) | 148990 | 0.05 | 
| chr17_48718114_48718630 | 1.43 | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 6154 | 0.13 | 
| chr18_43901802_43901953 | 1.38 | RNF165 | ring finger protein 165 | 4895 | 0.31 | 
| chr9_101746221_101746372 | 1.37 | RP11-92C4.6 |  | 40239 | 0.15 | 
| chr10_60542850_60543245 | 1.36 | BICC1 | bicaudal C homolog 1 (Drosophila) | 10248 | 0.3 | 
| chr10_81923644_81923795 | 1.35 | ANXA11 | annexin A11 | 1951 | 0.35 | 
| chr8_13081961_13082497 | 1.34 | DLC1 | deleted in liver cancer 1 | 51826 | 0.15 | 
| chr11_92113404_92113555 | 1.33 | FAT3 | FAT atypical cadherin 3 | 27772 | 0.21 | 
| chr15_35984861_35985012 | 1.30 | DPH6 | diphthamine biosynthesis 6 | 146543 | 0.05 | 
| chr19_8094026_8094177 | 1.27 | CCL25 | chemokine (C-C motif) ligand 25 | 23550 | 0.11 | 
| chr6_33645473_33645624 | 1.27 | SBP1 | SBP1; Uncharacterized protein | 17926 | 0.13 | 
| chr10_21625403_21625600 | 1.25 | ENSG00000207264 | . | 14611 | 0.25 | 
| chr11_116861004_116861155 | 1.25 | ENSG00000264344 | . | 25166 | 0.14 | 
| chr1_64189357_64189508 | 1.24 | ROR1 | receptor tyrosine kinase-like orphan receptor 1 | 50261 | 0.14 | 
| chr22_36720442_36720593 | 1.22 | ENSG00000266345 | . | 8271 | 0.19 | 
| chr1_178620335_178620486 | 1.22 | ENSG00000266417 | . | 26474 | 0.17 | 
| chr11_118788584_118789146 | 1.21 | BCL9L | B-cell CLL/lymphoma 9-like | 748 | 0.43 | 
| chr6_33641254_33641439 | 1.20 | SBP1 | SBP1; Uncharacterized protein | 22128 | 0.12 | 
| chr11_35572250_35572401 | 1.19 | PAMR1 | peptidase domain containing associated with muscle regeneration 1 | 20477 | 0.22 | 
| chr2_95982705_95982856 | 1.18 | KCNIP3 | Kv channel interacting protein 3, calsenilin | 6810 | 0.24 | 
| chr3_124847786_124848016 | 1.18 | SLC12A8 | solute carrier family 12, member 8 | 8203 | 0.17 | 
| chr11_78507410_78507561 | 1.18 | TENM4 | teneurin transmembrane protein 4 | 8971 | 0.26 | 
| chr22_18543998_18544149 | 1.16 | XXbac-B476C20.9 |  | 16490 | 0.13 | 
| chr3_88191368_88191519 | 1.15 | ZNF654 | zinc finger protein 654 | 3189 | 0.24 | 
| chr1_26629293_26629444 | 1.14 | UBXN11 | UBX domain protein 11 | 139 | 0.93 | 
| chr17_71285096_71285247 | 1.13 | CDC42EP4 | CDC42 effector protein (Rho GTPase binding) 4 | 22376 | 0.14 | 
| chr1_27675350_27676002 | 1.12 | SYTL1 | synaptotagmin-like 1 | 4312 | 0.13 | 
| chr8_97596258_97596585 | 1.12 | SDC2 | syndecan 2 | 752 | 0.76 | 
| chr19_980614_980765 | 1.12 | WDR18 | WD repeat domain 18 | 3642 | 0.1 | 
| chr21_39243678_39243829 | 1.11 | KCNJ6 | potassium inwardly-rectifying channel, subfamily J, member 6 | 41804 | 0.18 | 
| chr17_45302121_45302272 | 1.10 | ENSG00000252088 | . | 4188 | 0.14 | 
| chr15_35998583_35998734 | 1.10 | DPH6 | diphthamine biosynthesis 6 | 160265 | 0.04 | 
| chr22_50968748_50969207 | 1.10 | TYMP | thymidine phosphorylase | 492 | 0.52 | 
| chr10_82233583_82234488 | 1.10 | TSPAN14 | tetraspanin 14 | 14977 | 0.2 | 
| chr11_115493188_115493339 | 1.09 | ENSG00000239153 | . | 4640 | 0.35 | 
| chr8_92331899_92332050 | 1.08 | SLC26A7 | solute carrier family 26 (anion exchanger), member 7 | 24122 | 0.23 | 
| chr18_7037812_7037963 | 1.08 | RP11-76K13.3 |  | 38929 | 0.15 | 
| chr1_115770004_115770155 | 1.07 | RP4-663N10.1 |  | 55576 | 0.15 | 
| chr2_218793997_218794279 | 1.07 | TNS1 | tensin 1 | 7747 | 0.24 | 
| chr11_118488575_118488790 | 1.07 | PHLDB1 | pleckstrin homology-like domain, family B, member 1 | 10324 | 0.11 | 
| chr2_20725549_20725700 | 1.06 | ENSG00000200829 | . | 45019 | 0.14 | 
| chr18_10058872_10059075 | 1.06 | ENSG00000263630 | . | 53779 | 0.15 | 
| chr9_100797630_100797781 | 1.05 | ENSG00000212521 | . | 3193 | 0.21 | 
| chr7_151297671_151297822 | 1.05 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 31693 | 0.18 | 
| chr2_69453519_69453670 | 1.04 | ENSG00000199460 | . | 43585 | 0.14 | 
| chr3_64448583_64448734 | 1.04 | PRICKLE2 | prickle homolog 2 (Drosophila) | 17506 | 0.23 | 
| chr2_112908956_112909107 | 1.04 | FBLN7 | fibulin 7 | 8294 | 0.25 | 
| chr16_4374038_4374189 | 1.04 | GLIS2 | GLIS family zinc finger 2 | 8112 | 0.13 | 
| chr11_20057064_20057215 | 1.03 | NAV2 | neuron navigator 2 | 12503 | 0.2 | 
| chr22_47331632_47331783 | 1.03 | ENSG00000221672 | . | 87904 | 0.09 | 
| chr1_86887854_86888005 | 1.03 | CLCA2 | chloride channel accessory 2 | 1840 | 0.38 | 
| chr14_52519431_52519582 | 1.03 | NID2 | nidogen 2 (osteonidogen) | 13836 | 0.2 | 
| chr4_170129389_170129540 | 1.03 | RP11-327O17.2 |  | 6519 | 0.28 | 
| chr20_19794933_19795263 | 1.03 | AL121761.2 | Uncharacterized protein | 56419 | 0.13 | 
| chr16_65158357_65158508 | 1.03 | CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 2164 | 0.49 | 
| chr8_22287581_22287732 | 1.02 | ENSG00000201761 | . | 4248 | 0.18 | 
| chr8_131495483_131495634 | 1.02 | ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 39652 | 0.22 | 
| chr18_53901184_53901335 | 1.02 | ENSG00000201816 | . | 154434 | 0.04 | 
| chr7_69680701_69680852 | 1.01 | AUTS2 | autism susceptibility candidate 2 | 513349 | 0.0 | 
| chr20_33705481_33705632 | 1.01 | ENSG00000201151 | . | 546 | 0.71 | 
| chr8_96023730_96023881 | 1.01 | NDUFAF6 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 | 13409 | 0.16 | 
| chr9_116387816_116387967 | 1.01 | RGS3 | regulator of G-protein signaling 3 | 32125 | 0.18 | 
| chr20_52390006_52390157 | 1.00 | ENSG00000238468 | . | 104784 | 0.07 | 
| chr11_3175380_3175656 | 1.00 | OSBPL5 | oxysterol binding protein-like 5 | 7105 | 0.16 | 
| chr7_46599110_46599261 | 1.00 | AC011294.3 | Uncharacterized protein | 137535 | 0.05 | 
| chr17_48287279_48287648 | 1.00 | COL1A1 | collagen, type I, alpha 1 | 8470 | 0.12 | 
| chr11_116663349_116663500 | 0.99 | APOA5 | apolipoprotein A-V | 288 | 0.82 | 
| chr1_149993326_149993477 | 0.99 | OTUD7B | OTU domain containing 7B | 10776 | 0.15 | 
| chr10_49798371_49798534 | 0.98 | ARHGAP22 | Rho GTPase activating protein 22 | 14545 | 0.21 | 
| chr10_112155772_112156026 | 0.98 | ENSG00000221359 | . | 38100 | 0.16 | 
| chr18_19863132_19863283 | 0.98 | ENSG00000238907 | . | 22668 | 0.2 | 
| chr19_11313952_11314103 | 0.98 | CTC-510F12.2 |  | 277 | 0.81 | 
| chr3_193988628_193988889 | 0.97 | CPN2 | carboxypeptidase N, polypeptide 2 | 83289 | 0.08 | 
| chr9_695165_695342 | 0.97 | RP11-130C19.3 |  | 9698 | 0.22 | 
| chr22_36719838_36719989 | 0.96 | ENSG00000266345 | . | 7667 | 0.2 | 
| chr1_215550097_215550248 | 0.96 | KCTD3 | potassium channel tetramerization domain containing 3 | 190563 | 0.03 | 
| chr22_36289790_36289941 | 0.95 | RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 45080 | 0.18 | 
| chr4_26034035_26034186 | 0.94 | SMIM20 | small integral membrane protein 20 | 118179 | 0.06 | 
| chr2_20650155_20650306 | 0.93 | RHOB | ras homolog family member B | 3395 | 0.25 | 
| chr2_119988548_119988699 | 0.93 | STEAP3 | STEAP family member 3, metalloreductase | 7194 | 0.2 | 
| chr12_113669340_113669491 | 0.92 | TPCN1 | two pore segment channel 1 | 6366 | 0.14 | 
| chr2_138843483_138843634 | 0.92 | HNMT | histamine N-methyltransferase | 121515 | 0.07 | 
| chr5_134476986_134477137 | 0.92 | PITX1 | paired-like homeodomain 1 | 106558 | 0.06 | 
| chr2_114087211_114087362 | 0.92 | PAX8 | paired box 8 | 50759 | 0.11 | 
| chr2_64515406_64515557 | 0.92 | ENSG00000264297 | . | 52412 | 0.14 | 
| chr12_31158813_31158964 | 0.91 | DDX11-AS1 | DDX11 antisense RNA 1 | 54796 | 0.12 | 
| chr12_122500947_122501514 | 0.91 | MLXIP | MLX interacting protein | 15398 | 0.2 | 
| chr15_68935670_68935966 | 0.91 | CORO2B | coronin, actin binding protein, 2B | 11491 | 0.29 | 
| chr17_45955898_45956049 | 0.91 | SP2 | Sp2 transcription factor | 17543 | 0.1 | 
| chr17_60897719_60897987 | 0.90 | MARCH10 | membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase | 12148 | 0.25 | 
| chr5_95193163_95193314 | 0.90 | ENSG00000250362 | . | 4252 | 0.16 | 
| chr15_58734384_58734535 | 0.89 | LIPC | lipase, hepatic | 10269 | 0.2 | 
| chr16_4367855_4368006 | 0.88 | GLIS2 | GLIS family zinc finger 2 | 3168 | 0.18 | 
| chr3_137797507_137797658 | 0.88 | DZIP1L | DAZ interacting zinc finger protein 1-like | 11100 | 0.21 | 
| chr2_72058073_72058224 | 0.88 | CYP26B1 | cytochrome P450, family 26, subfamily B, polypeptide 1 | 312065 | 0.01 | 
| chr10_235006_235157 | 0.88 | ZMYND11 | zinc finger, MYND-type containing 11 | 9128 | 0.22 | 
| chr12_64581703_64581854 | 0.87 | ENSG00000212298 | . | 16795 | 0.15 | 
| chr1_217698965_217699116 | 0.87 | RP11-361K17.2 |  | 33723 | 0.22 | 
| chr10_93368479_93368630 | 0.87 | PPP1R3C | protein phosphatase 1, regulatory subunit 3C | 24257 | 0.25 | 
| chr5_133289150_133289301 | 0.87 | C5orf15 | chromosome 5 open reading frame 15 | 15253 | 0.23 | 
| chr10_90014178_90014329 | 0.87 | ENSG00000200891 | . | 259801 | 0.02 | 
| chr16_89478717_89479580 | 0.86 | RP1-168P16.2 |  | 176 | 0.93 | 
| chr2_190015642_190015793 | 0.86 | ENSG00000264725 | . | 17880 | 0.2 | 
| chr8_129089317_129089468 | 0.86 | ENSG00000221176 | . | 27994 | 0.18 | 
| chr3_126721664_126721815 | 0.86 | PLXNA1 | plexin A1 | 14302 | 0.28 | 
| chr14_104129844_104129995 | 0.85 | KLC1 | kinesin light chain 1 | 9773 | 0.09 | 
| chr7_140307767_140307918 | 0.85 | ENSG00000201354 | . | 1805 | 0.26 | 
| chr3_53184032_53184571 | 0.85 | PRKCD | protein kinase C, delta | 5724 | 0.19 | 
| chr1_7531690_7531864 | 0.85 | RP4-549F15.1 |  | 30163 | 0.21 | 
| chr6_109561464_109561868 | 0.85 | ENSG00000238474 | . | 50895 | 0.12 | 
| chr1_94730682_94730833 | 0.85 | ARHGAP29 | Rho GTPase activating protein 29 | 27568 | 0.21 | 
| chr10_114572643_114572794 | 0.85 | RP11-57H14.4 |  | 10531 | 0.26 | 
| chr2_46557321_46557472 | 0.85 | EPAS1 | endothelial PAS domain protein 1 | 32855 | 0.2 | 
| chr3_194930783_194931056 | 0.84 | ENSG00000206600 | . | 4597 | 0.2 | 
| chr3_195612690_195612841 | 0.84 | TNK2 | tyrosine kinase, non-receptor, 2 | 2690 | 0.21 | 
| chr4_41145105_41145256 | 0.84 | ENSG00000207198 | . | 29221 | 0.18 | 
| chr11_12088585_12089097 | 0.84 | MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 | 26702 | 0.22 | 
| chr3_126680391_126680542 | 0.84 | PLXNA1 | plexin A1 | 26971 | 0.25 | 
| chr14_55238525_55238676 | 0.84 | SAMD4A | sterile alpha motif domain containing 4A | 17049 | 0.24 | 
| chr15_57513605_57513971 | 0.83 | TCF12 | transcription factor 12 | 2124 | 0.42 | 
| chr14_68989421_68989674 | 0.83 | CTD-2325P2.4 |  | 105615 | 0.07 | 
| chr20_17660563_17661274 | 0.83 | RRBP1 | ribosome binding protein 1 | 1787 | 0.38 | 
| chr16_31464776_31464980 | 0.83 | ARMC5 | armadillo repeat containing 5 | 4523 | 0.1 | 
| chr5_33734273_33734424 | 0.83 | ENSG00000201623 | . | 153919 | 0.04 | 
| chr3_8551269_8551420 | 0.82 | LMCD1 | LIM and cysteine-rich domains 1 | 7772 | 0.22 | 
| chr10_75924551_75924986 | 0.82 | ADK | adenosine kinase | 11676 | 0.2 | 
| chr12_123336731_123337286 | 0.82 | HIP1R | huntingtin interacting protein 1 related | 7704 | 0.18 | 
| chr9_137394449_137394849 | 0.82 | RXRA | retinoid X receptor, alpha | 96221 | 0.07 | 
| chr1_22188300_22188451 | 0.82 | HSPG2 | heparan sulfate proteoglycan 2 | 6486 | 0.2 | 
| chr7_143028312_143028615 | 0.81 | CLCN1 | chloride channel, voltage-sensitive 1 | 15244 | 0.1 | 
| chr11_45202971_45203158 | 0.81 | PRDM11 | PR domain containing 11 | 364 | 0.9 | 
| chr10_45356464_45356615 | 0.81 | TMEM72 | transmembrane protein 72 | 50109 | 0.12 | 
| chr10_13908243_13908394 | 0.81 | FRMD4A | FERM domain containing 4A | 7406 | 0.26 | 
| chr17_70687944_70688095 | 0.80 | ENSG00000222545 | . | 22591 | 0.21 | 
| chr20_34055509_34055660 | 0.80 | CEP250 | centrosomal protein 250kDa | 5494 | 0.12 | 
| chr3_23919325_23919591 | 0.80 | RPL15 | ribosomal protein L15 | 38578 | 0.14 | 
| chr7_25886928_25887079 | 0.80 | ENSG00000199085 | . | 102603 | 0.08 | 
| chr2_43181551_43181728 | 0.80 | ENSG00000207087 | . | 136993 | 0.05 | 
| chr6_90713473_90713624 | 0.80 | ENSG00000222078 | . | 2323 | 0.34 | 
| chr2_74755282_74756348 | 0.80 | HTRA2 | HtrA serine peptidase 2 | 689 | 0.35 | 
| chr2_200274877_200275028 | 0.79 | SATB2 | SATB homeobox 2 | 45859 | 0.16 | 
| chr1_55887073_55887224 | 0.79 | ENSG00000252162 | . | 22961 | 0.21 | 
| chr8_119451199_119451350 | 0.79 | SAMD12 | sterile alpha motif domain containing 12 | 141847 | 0.05 | 
| chr4_5754934_5755085 | 0.79 | EVC | Ellis van Creveld syndrome | 42067 | 0.17 | 
| chr7_66417549_66417700 | 0.79 | TMEM248 | transmembrane protein 248 | 22013 | 0.14 | 
| chr20_37055054_37055242 | 0.79 | ENSG00000225091 | . | 937 | 0.29 | 
| chr22_30194899_30195349 | 0.79 | ASCC2 | activating signal cointegrator 1 complex subunit 2 | 2967 | 0.2 | 
| chr13_31447036_31447219 | 0.78 | MEDAG | mesenteric estrogen-dependent adipogenesis | 33201 | 0.17 | 
| chr5_37792745_37792896 | 0.78 | ENSG00000238335 | . | 9347 | 0.25 | 
| chr7_100751782_100751933 | 0.78 | RP11-395B7.7 |  | 14529 | 0.1 | 
| chr12_27776932_27777083 | 0.78 | PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | 24726 | 0.18 | 
| chr4_119910886_119911150 | 0.77 | SYNPO2 | synaptopodin 2 | 33608 | 0.22 | 
| chr18_9827718_9828105 | 0.77 | ENSG00000242651 | . | 2713 | 0.27 | 
| chr8_90810257_90810408 | 0.77 | RIPK2 | receptor-interacting serine-threonine kinase 2 | 40270 | 0.19 | 
| chr5_64603338_64603489 | 0.76 | ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | 166105 | 0.03 | 
| chr17_35837052_35837353 | 0.76 | DUSP14 | dual specificity phosphatase 14 | 12735 | 0.18 | 
| chr3_123414639_123414914 | 0.76 | MYLK | myosin light chain kinase | 3550 | 0.22 | 
| chr3_11643240_11643537 | 0.76 | VGLL4 | vestigial like 4 (Drosophila) | 2667 | 0.27 | 
| chr16_80308751_80309048 | 0.76 | DYNLRB2 | dynein, light chain, roadblock-type 2 | 265732 | 0.02 | 
| chr16_70726821_70726972 | 0.76 | VAC14 | Vac14 homolog (S. cerevisiae) | 2600 | 0.21 | 
| chr18_10377597_10377748 | 0.76 | ENSG00000239031 | . | 12325 | 0.27 | 
| chr10_25179230_25179428 | 0.75 | ENSG00000240294 | . | 18412 | 0.23 | 
| chr5_134727254_134728171 | 0.75 | H2AFY | H2A histone family, member Y | 7189 | 0.17 | 
| chr1_201469880_201470164 | 0.75 | CSRP1 | cysteine and glycine-rich protein 1 | 4321 | 0.18 | 
| chr16_89722843_89723402 | 0.75 | CHMP1A | charged multivesicular body protein 1A | 936 | 0.31 | 
| chr7_46525977_46526128 | 0.75 | AC011294.3 | Uncharacterized protein | 210668 | 0.03 | 
| chr2_20795415_20795848 | 0.74 | HS1BP3-IT1 | HS1BP3 intronic transcript 1 (non-protein coding) | 3323 | 0.28 | 
| chr12_67829798_67829949 | 0.74 | CAND1 | cullin-associated and neddylation-dissociated 1 | 137121 | 0.05 | 
| chr8_130722966_130723117 | 0.74 | GSDMC | gasdermin C | 76093 | 0.1 | 
| chr3_14629533_14629684 | 0.74 | ENSG00000207163 | . | 57013 | 0.11 | 
| chr17_39677520_39677671 | 0.74 | KRT15 | keratin 15 | 324 | 0.76 | 
| chr19_4052225_4052489 | 0.74 | AC016586.1 |  | 9203 | 0.11 | 
| chr1_94204476_94204635 | 0.74 | RP11-488P3.1 |  | 36445 | 0.17 | 
| chr5_132151212_132151363 | 0.74 | SOWAHA | sosondowah ankyrin repeat domain family member A | 2254 | 0.19 | 
| chr17_63283314_63283465 | 0.74 | ENSG00000265189 | . | 133389 | 0.05 | 
| chr17_40066650_40066801 | 0.74 | ACLY | ATP citrate lyase | 8479 | 0.12 | 
| chr10_80908954_80909824 | 0.74 | ZMIZ1 | zinc finger, MIZ-type containing 1 | 80597 | 0.1 | 
| chr2_131584643_131584794 | 0.73 | AC133785.1 |  | 9849 | 0.17 | 
| chr3_115525487_115525638 | 0.73 | ENSG00000243359 | . | 31153 | 0.25 | 
| chr3_194215161_194215312 | 0.73 | LINC00884 | long intergenic non-protein coding RNA 884 | 3452 | 0.18 | 
| chr5_176922531_176922891 | 0.73 | RP11-1334A24.6 |  | 715 | 0.41 | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.2 | 1.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) | 
| 0.2 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) | 
| 0.2 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) | 
| 0.2 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) | 
| 0.2 | 0.6 | GO:0048548 | regulation of pinocytosis(GO:0048548) | 
| 0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) | 
| 0.1 | 0.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) | 
| 0.1 | 0.5 | GO:0071731 | response to nitric oxide(GO:0071731) | 
| 0.1 | 0.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) | 
| 0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) | 
| 0.1 | 1.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) | 
| 0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) | 
| 0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) | 
| 0.1 | 0.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) | 
| 0.1 | 0.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) | 
| 0.1 | 0.3 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) | 
| 0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) | 
| 0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) | 
| 0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) | 
| 0.1 | 1.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) | 
| 0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) | 
| 0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) | 
| 0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) | 
| 0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) | 
| 0.1 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) | 
| 0.1 | 0.3 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) | 
| 0.1 | 0.3 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) | 
| 0.1 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) | 
| 0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) | 
| 0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) | 
| 0.1 | 0.4 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) | 
| 0.1 | 0.4 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) | 
| 0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) | 
| 0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) | 
| 0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) | 
| 0.1 | 0.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) | 
| 0.1 | 0.3 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) | 
| 0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) | 
| 0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) | 
| 0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) | 
| 0.1 | 1.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) | 
| 0.1 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) | 
| 0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) | 
| 0.1 | 0.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) | 
| 0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) | 
| 0.1 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) | 
| 0.1 | 0.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) | 
| 0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) | 
| 0.1 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) | 
| 0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) | 
| 0.1 | 0.6 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) | 
| 0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) | 
| 0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) | 
| 0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) | 
| 0.1 | 0.6 | GO:0031000 | response to caffeine(GO:0031000) | 
| 0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) | 
| 0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) | 
| 0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) | 
| 0.1 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) | 
| 0.1 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) | 
| 0.1 | 0.2 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) | 
| 0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) | 
| 0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) | 
| 0.1 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) | 
| 0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) | 
| 0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) | 
| 0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) | 
| 0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) | 
| 0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) | 
| 0.1 | 0.3 | GO:0071548 | response to dexamethasone(GO:0071548) | 
| 0.1 | 0.1 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) | 
| 0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) | 
| 0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) | 
| 0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) | 
| 0.1 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) | 
| 0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) | 
| 0.1 | 1.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) | 
| 0.1 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) | 
| 0.1 | 1.0 | GO:0048844 | artery morphogenesis(GO:0048844) | 
| 0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) | 
| 0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) | 
| 0.1 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) | 
| 0.1 | 0.2 | GO:0022601 | menstrual cycle phase(GO:0022601) | 
| 0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) | 
| 0.1 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) | 
| 0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) | 
| 0.1 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) | 
| 0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) | 
| 0.1 | 0.1 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) | 
| 0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) | 
| 0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) | 
| 0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) | 
| 0.1 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) | 
| 0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) | 
| 0.1 | 0.1 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) | 
| 0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) | 
| 0.1 | 0.1 | GO:0090189 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) | 
| 0.1 | 0.3 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) | 
| 0.0 | 0.0 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) | 
| 0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) | 
| 0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) | 
| 0.0 | 0.1 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) | 
| 0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) | 
| 0.0 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) | 
| 0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) | 
| 0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) | 
| 0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) | 
| 0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) | 
| 0.0 | 0.0 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) | 
| 0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) | 
| 0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) | 
| 0.0 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) | 
| 0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) | 
| 0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) | 
| 0.0 | 0.4 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) | 
| 0.0 | 0.2 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) | 
| 0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) | 
| 0.0 | 0.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) | 
| 0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) | 
| 0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) | 
| 0.0 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) | 
| 0.0 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) | 
| 0.0 | 0.6 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) | 
| 0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) | 
| 0.0 | 0.2 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) | 
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) | 
| 0.0 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) | 
| 0.0 | 0.1 | GO:0060841 | venous blood vessel development(GO:0060841) | 
| 0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) | 
| 0.0 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) | 
| 0.0 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) | 
| 0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) | 
| 0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) | 
| 0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) | 
| 0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) | 
| 0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) | 
| 0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) | 
| 0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) | 
| 0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) | 
| 0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) | 
| 0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) | 
| 0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) | 
| 0.0 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) positive regulation of amino acid transport(GO:0051957) | 
| 0.0 | 0.2 | GO:0060039 | pericardium development(GO:0060039) | 
| 0.0 | 0.2 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) | 
| 0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) | 
| 0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) | 
| 0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) | 
| 0.0 | 0.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) | 
| 0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) | 
| 0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) | 
| 0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) | 
| 0.0 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) | 
| 0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) | 
| 0.0 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) | 
| 0.0 | 0.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) | 
| 0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) | 
| 0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) | 
| 0.0 | 0.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) | 
| 0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) | 
| 0.0 | 0.1 | GO:0010171 | body morphogenesis(GO:0010171) | 
| 0.0 | 0.5 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) | 
| 0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) | 
| 0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) | 
| 0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) | 
| 0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) | 
| 0.0 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) | 
| 0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) | 
| 0.0 | 0.1 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) | 
| 0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) | 
| 0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) | 
| 0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) | 
| 0.0 | 0.3 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) | 
| 0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) | 
| 0.0 | 0.3 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) | 
| 0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) | 
| 0.0 | 0.3 | GO:0030878 | thyroid gland development(GO:0030878) | 
| 0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) | 
| 0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) | 
| 0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) | 
| 0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) | 
| 0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) | 
| 0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) | 
| 0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) | 
| 0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) | 
| 0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) | 
| 0.0 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) | 
| 0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) | 
| 0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) | 
| 0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) | 
| 0.0 | 0.3 | GO:0061036 | positive regulation of cartilage development(GO:0061036) | 
| 0.0 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) | 
| 0.0 | 0.3 | GO:0048265 | response to pain(GO:0048265) | 
| 0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) | 
| 0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) | 
| 0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) | 
| 0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) | 
| 0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) | 
| 0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) | 
| 0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) | 
| 0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) | 
| 0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) | 
| 0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) | 
| 0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) | 
| 0.0 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) | 
| 0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) | 
| 0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) | 
| 0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) | 
| 0.0 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) | 
| 0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) | 
| 0.0 | 0.1 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) | 
| 0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) | 
| 0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) | 
| 0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) | 
| 0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) | 
| 0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) | 
| 0.0 | 0.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) | 
| 0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) | 
| 0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) | 
| 0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) | 
| 0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) | 
| 0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) | 
| 0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) | 
| 0.0 | 0.1 | GO:0010659 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) | 
| 0.0 | 0.1 | GO:0031076 | embryonic camera-type eye development(GO:0031076) | 
| 0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) | 
| 0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) | 
| 0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) | 
| 0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) | 
| 0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) | 
| 0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) | 
| 0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) | 
| 0.0 | 0.2 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) | 
| 0.0 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) | 
| 0.0 | 0.2 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) | 
| 0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) | 
| 0.0 | 0.1 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) | 
| 0.0 | 0.1 | GO:0090398 | cellular senescence(GO:0090398) | 
| 0.0 | 0.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) | 
| 0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) | 
| 0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) | 
| 0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) | 
| 0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) | 
| 0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) | 
| 0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) | 
| 0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) | 
| 0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) | 
| 0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) | 
| 0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) | 
| 0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) | 
| 0.0 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) | 
| 0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) | 
| 0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) | 
| 0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) | 
| 0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) | 
| 0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) | 
| 0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) | 
| 0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) | 
| 0.0 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) | 
| 0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) | 
| 0.0 | 0.1 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) | 
| 0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) | 
| 0.0 | 0.9 | GO:0006821 | chloride transport(GO:0006821) | 
| 0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) | 
| 0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) | 
| 0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) | 
| 0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) | 
| 0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) | 
| 0.0 | 0.0 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) | 
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) | 
| 0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) | 
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) | 
| 0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) | 
| 0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) | 
| 0.0 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) | 
| 0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) | 
| 0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) | 
| 0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) | 
| 0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) | 
| 0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) | 
| 0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) | 
| 0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) | 
| 0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) | 
| 0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) | 
| 0.0 | 0.1 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) | 
| 0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) | 
| 0.0 | 0.0 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) | 
| 0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) | 
| 0.0 | 0.1 | GO:0060968 | regulation of gene silencing(GO:0060968) | 
| 0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) | 
| 0.0 | 0.8 | GO:0006446 | regulation of translational initiation(GO:0006446) | 
| 0.0 | 0.0 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) | 
| 0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) | 
| 0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) | 
| 0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) | 
| 0.0 | 0.0 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) | 
| 0.0 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) | 
| 0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) | 
| 0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) | 
| 0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) | 
| 0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) | 
| 0.0 | 0.1 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) | 
| 0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) | 
| 0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) | 
| 0.0 | 0.2 | GO:0007405 | neuroblast proliferation(GO:0007405) | 
| 0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) | 
| 0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) | 
| 0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) | 
| 0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) | 
| 0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) | 
| 0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) | 
| 0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) | 
| 0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) | 
| 0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) | 
| 0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) | 
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) | 
| 0.0 | 0.1 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) | 
| 0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) | 
| 0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) | 
| 0.0 | 0.1 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) | 
| 0.0 | 0.8 | GO:0051291 | protein heterooligomerization(GO:0051291) | 
| 0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) | 
| 0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) | 
| 0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) | 
| 0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) | 
| 0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) | 
| 0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) | 
| 0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) | 
| 0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) | 
| 0.0 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) | 
| 0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) | 
| 0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) | 
| 0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) | 
| 0.0 | 0.2 | GO:0033574 | response to testosterone(GO:0033574) | 
| 0.0 | 0.2 | GO:0021954 | central nervous system neuron development(GO:0021954) | 
| 0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) | 
| 0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) | 
| 0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) | 
| 0.0 | 0.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) | 
| 0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) | 
| 0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) | 
| 0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) | 
| 0.0 | 0.0 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) | 
| 0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) | 
| 0.0 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) | 
| 0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) | 
| 0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) | 
| 0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) | 
| 0.0 | 0.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) | 
| 0.0 | 0.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) | 
| 0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) | 
| 0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) | 
| 0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) | 
| 0.0 | 0.1 | GO:0009994 | oocyte differentiation(GO:0009994) oocyte development(GO:0048599) | 
| 0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) | 
| 0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) | 
| 0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) | 
| 0.0 | 0.0 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) | 
| 0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) | 
| 0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) | 
| 0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) | 
| 0.0 | 0.2 | GO:0007569 | cell aging(GO:0007569) | 
| 0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) | 
| 0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) | 
| 0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) | 
| 0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) | 
| 0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) | 
| 0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) | 
| 0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) | 
| 0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) | 
| 0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) | 
| 0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) | 
| 0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) | 
| 0.0 | 0.1 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) | 
| 0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) | 
| 0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) | 
| 0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) | 
| 0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) | 
| 0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) | 
| 0.0 | 0.0 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) | 
| 0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) | 
| 0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) | 
| 0.0 | 0.1 | GO:0046039 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) GTP metabolic process(GO:0046039) prosthetic group metabolic process(GO:0051189) | 
| 0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) | 
| 0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) | 
| 0.0 | 0.0 | GO:1903008 | organelle disassembly(GO:1903008) | 
| 0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) | 
| 0.0 | 0.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) | 
| 0.0 | 0.0 | GO:0060295 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) | 
| 0.0 | 0.0 | GO:0046931 | pore complex assembly(GO:0046931) | 
| 0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) | 
| 0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) | 
| 0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) | 
| 0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) | 
| 0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) | 
| 0.0 | 0.0 | GO:0042448 | progesterone metabolic process(GO:0042448) | 
| 0.0 | 0.2 | GO:0005980 | glycogen catabolic process(GO:0005980) | 
| 0.0 | 0.0 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) | 
| 0.0 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) | 
| 0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) | 
| 0.0 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) | 
| 0.0 | 0.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) | 
| 0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) | 
| 0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) | 
| 0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) | 
| 0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) | 
| 0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) | 
| 0.0 | 0.1 | GO:0021987 | cerebral cortex development(GO:0021987) | 
| 0.0 | 0.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) | 
| 0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) | 
| 0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) | 
| 0.0 | 0.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) | 
| 0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) | 
| 0.0 | 0.1 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) | 
| 0.0 | 0.0 | GO:0008347 | glial cell migration(GO:0008347) | 
| 0.0 | 0.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) | 
| 0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) | 
| 0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) | 
| 0.0 | 0.1 | GO:1901998 | antibiotic transport(GO:0042891) toxin transport(GO:1901998) | 
| 0.0 | 0.0 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.2 | 0.7 | GO:0032449 | CBM complex(GO:0032449) | 
| 0.2 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) | 
| 0.2 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) | 
| 0.1 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) | 
| 0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) | 
| 0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) | 
| 0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) | 
| 0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) | 
| 0.1 | 0.8 | GO:0098651 | basement membrane collagen trimer(GO:0098651) | 
| 0.1 | 0.3 | GO:0043260 | laminin-11 complex(GO:0043260) | 
| 0.1 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) | 
| 0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) | 
| 0.1 | 0.2 | GO:0030673 | axolemma(GO:0030673) | 
| 0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) | 
| 0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) | 
| 0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) | 
| 0.1 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) | 
| 0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) | 
| 0.1 | 1.5 | GO:0032432 | actin filament bundle(GO:0032432) | 
| 0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) | 
| 0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) | 
| 0.1 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) | 
| 0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) | 
| 0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) | 
| 0.0 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) | 
| 0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) | 
| 0.0 | 0.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) | 
| 0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) | 
| 0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) | 
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) | 
| 0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) | 
| 0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) | 
| 0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) | 
| 0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) | 
| 0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) | 
| 0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) | 
| 0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) | 
| 0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) | 
| 0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) | 
| 0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) | 
| 0.0 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) | 
| 0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) | 
| 0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) | 
| 0.0 | 0.4 | GO:0005581 | collagen trimer(GO:0005581) | 
| 0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) | 
| 0.0 | 0.2 | GO:0031430 | M band(GO:0031430) | 
| 0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) | 
| 0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) | 
| 0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) | 
| 0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) | 
| 0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) | 
| 0.0 | 1.3 | GO:0005604 | basement membrane(GO:0005604) | 
| 0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) cell cortex region(GO:0099738) | 
| 0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) | 
| 0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) | 
| 0.0 | 0.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) | 
| 0.0 | 0.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) | 
| 0.0 | 0.1 | GO:0031672 | A band(GO:0031672) | 
| 0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) | 
| 0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) | 
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) | 
| 0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) | 
| 0.0 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) | 
| 0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) | 
| 0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) | 
| 0.0 | 4.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) | 
| 0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) | 
| 0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) | 
| 0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) | 
| 0.0 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) | 
| 0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) | 
| 0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) | 
| 0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) | 
| 0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) | 
| 0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) | 
| 0.0 | 0.1 | GO:0030315 | T-tubule(GO:0030315) | 
| 0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) | 
| 0.0 | 0.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) | 
| 0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) | 
| 0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) | 
| 0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) | 
| 0.0 | 0.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) | 
| 0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) | 
| 0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) | 
| 0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) | 
| 0.0 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) | 
| 0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) | 
| 0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) | 
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) | 
| 0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) | 
| 0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) | 
| 0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) | 
| 0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) | 
| 0.0 | 0.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) | 
| 0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) | 
| 0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) | 
| 0.0 | 0.0 | GO:0042405 | nuclear inclusion body(GO:0042405) | 
| 0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) | 
| 0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) | 
| 0.0 | 0.0 | GO:0001940 | male pronucleus(GO:0001940) | 
| 0.0 | 0.1 | GO:0031674 | I band(GO:0031674) | 
| 0.0 | 0.1 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) | 
| 0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) | 
| 0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) | 
| 0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) | 
| 0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) | 
| 0.0 | 0.1 | GO:0044452 | nucleolar part(GO:0044452) | 
| 0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) | 
| 0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) | 
| 0.0 | 1.7 | GO:0044297 | cell body(GO:0044297) | 
| 0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) | 
| 0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) | 
| 0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) | 
| 0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) | 
| 0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) | 
| 0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.3 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) | 
| 0.2 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) | 
| 0.2 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) | 
| 0.2 | 0.7 | GO:0004470 | malic enzyme activity(GO:0004470) | 
| 0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) | 
| 0.1 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) | 
| 0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) | 
| 0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) | 
| 0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) | 
| 0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) | 
| 0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) | 
| 0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) | 
| 0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) | 
| 0.1 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) | 
| 0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) | 
| 0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) | 
| 0.1 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) | 
| 0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) | 
| 0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) | 
| 0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) | 
| 0.1 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) | 
| 0.1 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) | 
| 0.1 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) | 
| 0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) | 
| 0.1 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) | 
| 0.1 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) | 
| 0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) | 
| 0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) | 
| 0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) | 
| 0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) | 
| 0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) | 
| 0.1 | 0.4 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) | 
| 0.1 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) | 
| 0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) | 
| 0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) | 
| 0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) | 
| 0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) | 
| 0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) | 
| 0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) | 
| 0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) | 
| 0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) | 
| 0.1 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) | 
| 0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) | 
| 0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) | 
| 0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) | 
| 0.1 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) | 
| 0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) | 
| 0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) | 
| 0.1 | 0.6 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) | 
| 0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) | 
| 0.1 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) | 
| 0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) | 
| 0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) | 
| 0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) | 
| 0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) | 
| 0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) | 
| 0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) | 
| 0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) | 
| 0.0 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) | 
| 0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) | 
| 0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) | 
| 0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) | 
| 0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) | 
| 0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) | 
| 0.0 | 0.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) | 
| 0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) | 
| 0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) | 
| 0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) | 
| 0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) | 
| 0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) | 
| 0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) | 
| 0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) | 
| 0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) | 
| 0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) | 
| 0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) | 
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) | 
| 0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) | 
| 0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) | 
| 0.0 | 3.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) | 
| 0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) | 
| 0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) | 
| 0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) | 
| 0.0 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) | 
| 0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) | 
| 0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) | 
| 0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) | 
| 0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) | 
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) | 
| 0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) | 
| 0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) | 
| 0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) | 
| 0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) | 
| 0.0 | 0.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) | 
| 0.0 | 0.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) | 
| 0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) | 
| 0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) | 
| 0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) | 
| 0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) | 
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) | 
| 0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) | 
| 0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) | 
| 0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) | 
| 0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) | 
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) | 
| 0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) | 
| 0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) | 
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) | 
| 0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) | 
| 0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) | 
| 0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) | 
| 0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) | 
| 0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) | 
| 0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) | 
| 0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) | 
| 0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) | 
| 0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) | 
| 0.0 | 0.3 | GO:0050840 | extracellular matrix binding(GO:0050840) | 
| 0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) | 
| 0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) | 
| 0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) | 
| 0.0 | 1.3 | GO:0005178 | integrin binding(GO:0005178) | 
| 0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) | 
| 0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) | 
| 0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) | 
| 0.0 | 0.1 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) | 
| 0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) | 
| 0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) | 
| 0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) | 
| 0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) | 
| 0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) | 
| 0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) | 
| 0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) | 
| 0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) | 
| 0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) | 
| 0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) | 
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) | 
| 0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) | 
| 0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) | 
| 0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) | 
| 0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) | 
| 0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) | 
| 0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) | 
| 0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) | 
| 0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) | 
| 0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) | 
| 0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) | 
| 0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) | 
| 0.0 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) | 
| 0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) | 
| 0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) | 
| 0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) | 
| 0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) | 
| 0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) | 
| 0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) | 
| 0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) | 
| 0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) | 
| 0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) | 
| 0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) | 
| 0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) | 
| 0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) | 
| 0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) | 
| 0.0 | 0.2 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) | 
| 0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) | 
| 0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) | 
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) | 
| 0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) | 
| 0.0 | 0.2 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) | 
| 0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) | 
| 0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) | 
| 0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) | 
| 0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) | 
| 0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) | 
| 0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) | 
| 0.0 | 0.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) | 
| 0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) | 
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) | 
| 0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) | 
| 0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) | 
| 0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) | 
| 0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) | 
| 0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) | 
| 0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) | 
| 0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) | 
| 0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) | 
| 0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) | 
| 0.0 | 0.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) | 
| 0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) | 
| 0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) | 
| 0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) | 
| 0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) | 
| 0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) | 
| 0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) | 
| 0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) | 
| 0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) | 
| 0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) | 
| 0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) | 
| 0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) | 
| 0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) | 
| 0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) | 
| 0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) | 
| 0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) | 
| 0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) | 
| 0.0 | 0.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) | 
| 0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) | 
| 0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) | 
| 0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) | 
| 0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) | 
| 0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) | 
| 0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) | 
| 0.0 | 0.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) | 
| 0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) | 
| 0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) | 
| 0.0 | 0.0 | GO:0004407 | histone deacetylase activity(GO:0004407) | 
| 0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) | 
| 0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) | 
| 0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) | 
| 0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) | 
| 0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) | 
| 0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) | 
| 0.0 | 0.9 | GO:0005254 | chloride channel activity(GO:0005254) | 
| 0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) | 
| 0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) | 
| 0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) | 
| 0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) | 
| 0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) | 
| 0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) | 
| 0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) | 
| 0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) | 
| 0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) | 
| 0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) | 
| 0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) | 
| 0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) | 
| 0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) | 
| 0.0 | 0.0 | GO:0008443 | phosphofructokinase activity(GO:0008443) | 
| 0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) | 
| 0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) | 
| 0.0 | 0.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) | 
| 0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) | 
| 0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) | 
| 0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) | 
| 0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) | 
| 0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) | 
| 0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) | 
| 0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) | 
| 0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) | 
| 0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) | 
| 0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) | 
| 0.0 | 0.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) | 
| 0.0 | 0.2 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) | 
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) | 
| 0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) | 
| 0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) | 
| 0.0 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) | 
| 0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) | 
| 0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) | 
| 0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) | 
| 0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) | 
| 0.0 | 1.2 | GO:0008083 | growth factor activity(GO:0008083) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions | 
| 0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events | 
| 0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway | 
| 0.1 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events | 
| 0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling | 
| 0.0 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins | 
| 0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans | 
| 0.0 | 1.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions | 
| 0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes | 
| 0.0 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling | 
| 0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events | 
| 0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling | 
| 0.0 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway | 
| 0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. | 
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway | 
| 0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway | 
| 0.0 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events | 
| 0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway | 
| 0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes | 
| 0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte | 
| 0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity | 
| 0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity | 
| 0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling | 
| 0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events | 
| 0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway | 
| 0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway | 
| 0.0 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma | 
| 0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms | 
| 0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin | 
| 0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor | 
| 0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes | 
| 0.0 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly | 
| 0.0 | 3.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans | 
| 0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway | 
| 0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix | 
| 0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway | 
| 0.0 | 0.6 | PID PLK1 PATHWAY | PLK1 signaling events | 
| 0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase | 
| 0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway | 
| 0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network | 
| 0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III | 
| 0.0 | 0.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling | 
| 0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway | 
| 0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events | 
| 0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. | 
| 0.0 | 0.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. | 
| 0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network | 
| 0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein | 
| 0.1 | 2.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis | 
| 0.1 | 1.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction | 
| 0.1 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport | 
| 0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism | 
| 0.1 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions | 
| 0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) | 
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane | 
| 0.1 | 0.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival | 
| 0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening | 
| 0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation | 
| 0.0 | 2.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation | 
| 0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins | 
| 0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB | 
| 0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions | 
| 0.0 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins | 
| 0.0 | 0.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling | 
| 0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex | 
| 0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts | 
| 0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport | 
| 0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL | 
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis | 
| 0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions | 
| 0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP | 
| 0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle | 
| 0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation | 
| 0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta | 
| 0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis | 
| 0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK | 
| 0.0 | 0.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions | 
| 0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis | 
| 0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling | 
| 0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes | 
| 0.0 | 0.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand | 
| 0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation | 
| 0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo | 
| 0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling | 
| 0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR | 
| 0.0 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization | 
| 0.0 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline | 
| 0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters | 
| 0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation | 
| 0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation | 
| 0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism | 
| 0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus | 
| 0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events | 
| 0.0 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis | 
| 0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis | 
| 0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle | 
| 0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events | 
| 0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) | 
| 0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions | 
| 0.0 | 1.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides | 
| 0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements | 
| 0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) | 
| 0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol | 
| 0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism | 
| 0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants | 
| 0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate | 
| 0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock | 
| 0.0 | 0.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 
| 0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC | 
| 0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 
| 0.0 | 0.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling | 
| 0.0 | 0.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 
| 0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters | 
| 0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation | 
| 0.0 | 0.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors | 
| 0.0 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway | 
| 0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |